← Leaderboards
Samuel Scott Panter
Northern California Institute Res &Educ
$1,161,969
Attributed
$1,161,969
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $226.5K · FY2005–15$250K$187.5K$125K$62.5K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$1,161,969 · 2
VA$0 · 1
By mechanism
R01$749,122 · 1
R21$412,847 · 1
I01$0 · 1
Top collaborators
No co-investigators on record.
Most similar at Northern California Institute Res &Educ
Same institution · by research overlap
- Gary Cecchini$6,731,720
- Joel S Karliner$2,735,173
- Raymond A Swanson$9,086,742
- Mary O Gray$2,887,063
- Mark B Ratcliffe$9,261,643
Others in their field
Top investigators on “Behavior Test”
- Lawrence Corey · Fred Hutchinson Cancer Center$307,833,851
- Chanza Baytop · Westat, Inc.$271,217,917
- Peter B. Gilbert · Fred Hutchinson Cancer Center$169,453,616
- Deborah J Donnell · Fred Hutchinson Cancer Center$139,239,479
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$137,892,773
- Judith S. Currier · University Of California Los Angeles$137,892,773
Research focus
Behavior TestAdultBloodAnimalsBehavioralBypassAfghanistanBlood Brain BarrierBlood - Brain Barrier AnatomyBlood PressureBody Weight ChangesBrainAdhesivesCause Of DeathCerebral Ischemia /HypoxiaChelation TherapyChronicClinical TrialsCognitive FunctionControl GroupsCostDeferoxamineDeferoxamine MethanesulfonateAcute
Grant awards (9)
Intranasal deferoxamine to treat stroke in young and older, male and female rats$0
I01 · FY2015 · VA · contact PI
Intranasal deferoxamine to treat stroke in young and older, male and female rats$0
I01 · FY2014 · VA · contact PI
Intranasal deferoxamine to treat stroke in young and older, male and female rats$0
I01 · FY2013 · VA · contact PI
Intranasal deferoxamine to treat stroke in young and older, male and female rats$0
I01 · FY2012 · VA · contact PI
Intranasal Deferoxamine to Precondition Against Stroke$186,298
R21 · FY2006 · NS · contact PI
Intranasal Deferoxamine to Precondition Against Stroke$226,549
R21 · FY2005 · NS
MECHANISMS AND PREVENTION OF HEMOGLOBIN NEUROTOXICITY$256,786
R01 · FY2002 · HL
MECHANISMS AND PREVENTION OF HEMOGLOBIN NEUROTOXICITY$249,638
R01 · FY2001 · HL
MECHANISMS AND PREVENTION OF HEMOGLOBIN NEUROTOXICITY$242,698
R01 · FY2000 · HL